ALSP

ALSP, Inc. is a privately held company located in San Diego, California, developing small molecule drugs for the treatment of neurodegenerative diseases, initially focusing on Traumatic Brain Injury (TBI) and Alzheimer's Disease (AD). Our approach is to identify key enzymes in the brain, known as neurop蛋白酶, which are believed to produce bioactive peptides that cause these conditions. These enzymes become targets for screening compounds that inhibit neurop蛋白酶, thereby reducing the production of harmful peptides.